Our publications available in English are listed hereafter.
National annual reports on drug issues
Annual reports sent to the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) giving an overview of the latest developments on the drug problem in France.
Informational letters (approximately seven per year) with the results of epidemiological, sociological or economic studies on drug and drug addiction phenomena.
Drugs, key data
This eight-page document, produced by the OFDT, provides the most relevant figures for measuring and providing a quick overview of drug-related phenomena.
Drugs, international challenges
Informational letter on issues related to the supply of drugs and international trafficking in illicit substances.
Drugs and addictions; Cannabis, essential data and knowledge; Problem drug use prevalence in France.
Tools provided to professionals, policy-makers and researchers who wish to evaluate their interventions in the field of health, especially in drug-related harm reduction issues. Protocols, guidelines and other methodological approaches to data collection in the field of drug use.
Scientific papers written by OFDT staff members and published in the international literature.
Briefs, posters, maps
Briefs designed to respond to specific requests from authorities, posters made for conferences and other events throughout Europe; maps.
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.